torsdag 29 augusti 2013

ReNeuron's stem cell therapy wins orphan status - PharmaTimes

ReNeuron s stem cell therapy wins orphan statusPharmaTimesBoth the European Commission and US Food and Drug Administration have classed ReN003 an orphan drug for the treatment of retinitis pigmentosa, a group of hereditary progressive eye diseases that damage retinal cells and cause sight loss, which affect read more

http://blog.zandcell.com/reneurons-stem-cell-therapy-wins-orphan-status-pharmatimes/?utm_source=rss&utm_medium=rss&utm_campaign=reneurons-stem-cell-therapy-wins-orphan-status-pharmatimes

Inga kommentarer:

Skicka en kommentar